《全日總結》恆指升354點 藥股揚 石藥及翰森彈逾一成
上證指數重上3,000點,港股今日造好。恆指高開115點,其後升幅曾擴大至453點見17,497點,全日升354點或2.1%,收17,398點;國指升119點或2%,收5,979點;恆生科技指數升93點或2.5%,收3,806點。大市全日成交總額914.78億元,滬、深港通南下交易淨流入26.55億及15.36億元人民幣。
醫藥股急彈,石藥(01093.HK)及翰森(03692.HK)炒高10.8%及11.7%,中生製藥(01177.HK)及藥明生物(02269.HK)升9.8%及7.3%,信達生物(01801.HK)升6.4%。摩通指全球醫療科技公司第三季旗下中國收入頗為可觀,相關公司認為中國第三季醫療行業反貪腐運動並未導致程序量有重大變化。
內媒報道指將推動新一輪房改,內房股合景泰富(01813.HK)升10%,恆大(03333.HK)升6.3%,綠城中國(03900.HK)、新城(01030.HK)、富力(02777.HK)及遠洋(03377.HK)升3.6%至4%。物管股華潤萬象(01209.HK)及碧服(06098.HK)升7%及5.5%。潤地(01109.HK)擬分拆基礎設施REIT於深交所上市,股價升3.8%。
內銀股建行(00939.HK)首三季多賺3.1%,全日股價升0.7%。農行(01288.HK)升2.4%,工行(01398.HK)及中行(03988.HK)升1.3%及1.5%。內險股國壽(02628.HK)第三季淨利潤跌99%,股價跌0.7%。其他金融股方面,匯控(00005.HK)反彈1.7%報58.05元,港交所(00388.HK)及友邦(01299.HK)升1.8%及1.5%。渣打(02888.HK)昨午公布季績後股價挫逾一成,今日跌0.8%,恆生(00011.HK)升2.2%。
內地10月共批87款國產網絡遊戲,網易(09999.HK)遊戲《射雕》在列。網易升3.5%報169.3元。其餘科技股方面,阿里(09988.HK)升3.3%報82.4元,騰訊(00700.HK)升1.8%報292.8元,京東(09618.HK)及嗶哩嗶哩(09626.HK)升3.4%及4.4%。美團(03690.HK)升2.9%。東方甄選(01797.HK)及晶片股中芯(00981.HK)升6.2%及5.8%,京東健康(06618.HK)升6.7%。電動車股小鵬(09868.HK)升5%。
消費及旅遊股方面,青啤(00168.HK)、潤啤(00291.HK)、安踏(02020.HK)、李寧(02331.HK)、國航(00753.HK)、南航(01055.HK)及中免(01880.HK)升4%至4.7%。其他股份方面,本地餐飲股大家樂(00341.HK)炒高7.8%。龍源(00916.HK)及天齊鋰業(09696.HK)績後分別升9.5%及6%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.